158836-71-6
基本信息
nitroflurbiprofen
Nitroxybutyl flurbiprofen
[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, 4-(nitrooxy)butyl ester
物理化學(xué)性質(zhì)
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
2024/11/08 | HY-U00013 | 158836-71-6 Nitroflurbiprofen | 158836-71-6 | 1mg | 1600元 |
2024/11/08 | HY-U00013 | 158836-71-6 Nitroflurbiprofen | 158836-71-6 | 5mg | 3400元 |
2024/11/08 | HY-U00013 | 158836-71-6 Nitroflurbiprofen | 158836-71-6 | 10mg | 4700元 |
常見(jiàn)問(wèn)題列表
COX
|
In vivo hemodynamic measurements (n = 8/condition) and evaluation of the increased intrahepatic resistance by in situ perfusion (n=5/condition) are performed in rats with thioacetamide-induced cirrhosis that receive either Nitroflurbiprofen (45 mg/kg), Flurbiprofen (30 mg/kg, equimolar concentration to Nitroflurbiprofen), or vehicle by intraperitoneal injection 24 hours and 1 hour prior to the measurements. Treatment with Nitroflurbiprofen, an NO-releasing cyclooxygenase inhibitor, improves portal hypertension without major adverse effects in thioacetamide-induced cirrhotic rats by attenuating intrahepatic vascular resistance, endothelial dysfunction, and hepatic hyperreactivity to vasoconstrictors.